Can we boost #HIPEC effectiveness with Bromelain?
Exciting new research from #WFORCE group, reveals its dual action as a mucolytic and cytotoxic agent, against appendiceal cancer organoids. #cancerresearch #innovation
Dive in the study here: rdcu.be/dGZE2

Extremely thankful for the incredible opportunity to present our research at #targets23 in Boston last week! A huge shoutout to #AACR , #NCI , and #EORTC for providing this invaluable platform to share groundbreaking insights in our shared mission to combat cancer.

At #PSOGI getting ready for great event ⁦Kiran Turaga⁩

Practice changing paper in appendiceal cancer by Andreana N. Holowatyj 🇺🇦
👇
Inherited Cancer Susceptibility Gene Sequence Variations Among Patients With Appendix Cancer ja.ma/3A8qffy via JAMA Oncology

Organoids are important for all #rare cancers.
Longitudinal grow and storage into living tumor banks can neutralize the impact of rarity #WFORCE #AnnSurgONC
link.springer.com/article/10.124…
In the next 3 months we will share our work on #Merkel cell, #pheochromocytoma and #mesothelioma

Sarcoma organoids.
link.springer.com/article/10.124…

By far, the most stunning OR suite view I have ever seen -Baptist MDA, Jacksonville, FL-where Dr. Chouliaras started a peritoneal malignancy program !

Δεν περίμενα ποτέ να δω Ιανουάριο μήνα , όψιμα σύκα στον δέντρο καλυμμένα με χιόνι και την ίδια στιγμή ανθισμένα γεράνια στο μπαλκόνι....όσοι μεγάλωσαν Ελλάδα με καταλαβαίνουν στα σίγουρα ...αλλά και πάλι το κλίμα δεν είναι το ίδιο...

It is a great day for the #WFORCE team, having 2/5 making an impact articles, in the same communication from Annals of Surgical Oncology !

Monemvasia, Laconia, Greece, 90 min away from Sparta.

-Founded 583 AD.

-Check the fortified corridor connecting upper and lower medieval fortresses.

Reading history vs walking through history!

There are two types of summer :

summer …. and Greek summer.

Egremni, Lefkada, 12:50pm, absolutely no filters !

50 piece to win the championship.

motorolaus | #FearTheDeer

#WFORCE Teamwork at its best!
We were honored with a rare score for a rare primary.

Our 2nd R01 award in 6 months and probably NCI's first R01 dedicated exclusively to appendiceal cancer.

Humbled to be part of this talented team, fighting to make a difference in cancer care.

Our new pub in CCR is now early released online.

Immunotherapy effect on appendiceal cancer treated with CRS/HIPEC.

Can we possibly use organoid data to guide clinical trial enrollment in rare diseases?

Supported by the ACPMP and NORD grant.

clincancerres.aacrjournals.org/content/early/…

Thank you #curemeso for trusting #WFORCE with the Meso Foundation Grant ! We are passionate in the concept of using organoids in generation of adaptive immunity in peritoneal disease ! Congrats to our team !

Thank you NPR for spreading the exciting news !

wfdd.org/story/wake-for…

#WFORCE  was granted from NIH a critical first R01 to study tumor clonality in appendix and colon cancer treated with CRS/HIPEC.

Shoutout and gratitude to our passionate and talented team, dedicated to the cause of innovative ways to conquer cancer !!!

48% misclassified pathology in appendiceal cancer needs an unorthodox approach.
We collaborate with Wake Engineering for an AI/ machine learning algorithm to assist with proper classification. Will be reaching out for collective action. Stay tuned.
surgjournal.com/article/S0039-…